Natalizumab in the treatment of patients with multiple sclerosis: first experience. (Record no. 17433110)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01425 a2200397 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515090852.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200712s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0077-8923 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1196/annals.1423.049 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Mareckova, Helena |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20071212 |
| 245 00 - TITLE STATEMENT | |
| Title | Natalizumab in the treatment of patients with multiple sclerosis: first experience. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Annals of the New York Academy of Sciences |
| Date of publication, distribution, etc. | Sep 2007 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 465-73 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CD4-Positive T-Lymphocytes |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Multiple Sclerosis |
| General subdivision | cerebrospinal fluid |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Natalizumab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, CCR5 |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, CXCR3 |
| General subdivision | metabolism |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Havrdova, Eva |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Krasulova, Eva |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vankova, Zdenka |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Koberová, Michaela |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sterzl, Ivan |
| 773 0# - HOST ITEM ENTRY | |
| Title | Annals of the New York Academy of Sciences |
| Related parts | vol. 1110 |
| -- | p. 465-73 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1196/annals.1423.049">https://doi.org/10.1196/annals.1423.049</a> |
| Public note | Available from publisher's website |
No items available.